Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models

Frontiers in Synaptic Neuroscience

Volumn , Issue JUN, 2010, Pages

  Gatto, Cheryl L ^a   Broadie, Kendal ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

E I ratio; Excitation; Fragile X syndrome; GABA; Glutamate; Inhibition; Neurodevelopment; Synapse

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BETA NEUREXIN; FMRP PROTEIN; GEPHYRIN; MEF2 PROTEIN; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; NEUROLIGIN 1; NEUROLIGIN 2; NPAS4 PROTEIN; PASD 95 PROTEIN; PROTEIN; PROTEIN HOMER 1A; PROTEIN HOMER 1B; PUMILIO PROTEIN; SHANK PROTEIN; STAUFEN PROTEIN; UNCLASSIFIED DRUG;

AUTISM; BRAIN CORTEX; BRAIN FUNCTION; CELL MIGRATION; COGNITIVE DEFECT; CORPUS STRIATUM; EPILEPSY; FRAGILE X SYNDROME; GENE CONTROL; GENE MUTATION; GENETIC MODEL; GENETIC TRANSCRIPTION; HIPPOCAMPAL CA1 REGION; HUMAN; INTELLECTUAL IMPAIRMENT; MOLECULAR MECHANICS; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN SYNTHESIS; RETT SYNDROME; REVIEW; RNA BINDING; SOCIAL INTERACTION; SYNAPSE; SYNAPTOGENESIS; TRANSLATION REGULATION;

EID: 80052650281     PISSN: None     EISSN: 16633563     Source Type: Journal    
DOI: 10.3389/fnsyn.2010.00004     Document Type: Review

References (308)

1. Akerman, C. J., and Cline, H. T. (2007). Refining the roles of GABAergic signaling during neural circuit formation. Trends Neurosci. 30, 382-389.
2. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188.
3. APA. (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC.
4. Ariani, F., Hayek, G., Rondinella, D., Artuso, R., Mencarelli, M. A., Spanhol-Rosseto, A., Pollazzon, M., Buoni, S., Spiga, O., Ricciardi, S., Meloni, I., Longo, I., Mari, F., Broccoli, V., Zappella, M., and Renieri, A. (2008). FOXG1 is responsible for the congenital variant of Rett syndrome. Am. J. Hum. Genet. 83, 89-93.
5. Ashley, C. T. Jr., Wilkinson, K. D., Reines, D., and Warren, S. T. (1993). FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262, 563-566.
6. Bailey, D. B. Jr., Hatton, D. D., Skinner, M., and Mesibov, G. (2001a). Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome. J. Autism Dev. Disord. 31, 165-174.
7. Bailey, D. B. Jr., Hatton, D. D., Tassone, F., Skinner, M., and Taylor, A. K. (2001b). Variability in FMRP and early development in males with fragile X syndrome. Am. J. Ment. Retard. 106, 16-27.
8. Bakker, C., Verheij, C., Willemsen, R., and van der Helm, R. (1994). Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 78, 23-33.
9. Barbaro, J., and Dissanayake, C. (2009). Autism spectrum disorders in infancy and toddlerhood: a review of the evidence on early signs, early identification tools, and early diagnosis. J. Dev. Behav. Pediatr. 30, 447-459.
10. Barbosa, A. C., Kim, M. S., Ertunc, M., Adachi, M., Nelson, E. D., McAnally, J., Richardson, J. A., Kavalali, E. T., Monteggia, L. M., Bassel-Duby, R., and Olson, E. N. (2008). MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc. Natl. Acad. Sci. U.S.A. 105, 9391-9396.
11. Bassell, G. J., and Warren, S. T. (2008). Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201-214.
12. Bear, M. F. (2005). Therapeutic implications of the mGluR theory of fragile X mental retardation. Genes Brain Behav. 4, 393-398.
13. Bear, M. F., Huber, K. M., and Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370-377.
14. Belichenko, P. V., Oldfors, A., Hagberg, B., and Dahlstrom, A. (1994). Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 5, 1509-1513.
15. Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., and Francke, U. (2009). Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 514, 240-258.
16. Ben-Ari, Y. (2002). Excitatory actions of gaba during development: the nature of the nurture. Nat. rev. 3, 728-739.
17. Berry-Kravis, E. (2002). Epilepsy in fragile X syndrome. Dev. Med. Child Neurol. 44, 724-728.
18. Betancur, C., Sakurai, T., and Buxbaum, J. D. (2009). The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci. 32, 402-412.
19. Boeckers, T. M. (2006). The postsynaptic density. Cell Tissue Res. 326, 409-422.
20. Bolduc, F. V., Bell, K., Cox, H., Broadie, K. S., and Tully, T. (2008). Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat. Neurosci. 11, 1143-1145.
21. Bourgeron, T. (2009). A synaptic trek to autism. Curr. Opin. Neurobiol. 19, 231-234.
22. Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., and Worley, P. F. (1997). Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386, 284-288.
23. Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., Darnell, R. B., and Warren, S. T. (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477-487.
24. Bunyan, D. J., and Robinson, D. O. (2008). Multiple de novo mutations in the MECP2 gene. Genet. Test. 12, 373-375.
25. Buskin, J. N., and Hauschka, S. D. (1989). Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell. Biol. 9, 2627-2640.
26. Casanova, M. F. (2006). Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist 12, 435-441.
27. Casanova, M. F., Buxhoeveden, D., and Gomez, J. (2003). Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim. Neuroscientist 9, 496-507.
28. Casanova, M. F., Buxhoeveden, D. P., Switala, A. E., and Roy, E. (2002). Minicolumnar pathology in autism. Neurology 58, 428-432.
29. Castren, M., Tervonen, T., Karkkainen, V., Heinonen, S., Castren, E., Larsson, K., Bakker, C. E., Oostra, B. A., and Akerman, K. (2005). Altered differentiation of neural stem cells in fragile X syndrome. Proc. Natl. Acad. Sci. U.S.A. 102, 17834-17839.
30. Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., and Bagni, C. (2008). Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol. Psychiatry 63, 963-973.
31. Chahrour, M., and Zoghbi, H. Y. (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437.
32. Chang, S., Bray, S. M., Li, Z., Zarnescu, D. C., He, C., Jin, P., and Warren, S. T. (2008). Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat. Chem. Biol. 4, 256-263.
33. Chao, H. T., Zoghbi, H. Y., and Rosenmund, C. (2007). MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58-65.
34. Chapleau, C. A., Calfa, G. D., Lane, M. C., Albertson, A. J., Larimore, J. L., Kudo, S., Armstrong, D. L., Percy, A. K., and Pozzo-Miller, L. (2009). Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol. Dis. 35, 219-233.
35. Chen, G., Li, W., Zhang, Q. S., Regulski, M., Sinha, N., Barditch, J., Tully, T., Krainer, A. R., Zhang, M. Q., and Dubnau, J. (2008). Identification of synaptic targets of Drosophila pumilio. PLoS Comput. Biol. 4, e1000026. doi:10.1371/journal.pcbi.1000026.
36. Chen, R. Z., Akbarian, S., Tudor, M., and Jaenisch, R. (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327-331.
37. Chih, B., Engelman, H., and Scheiffele, P. (2005). Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324-1328.
38. Choonara, Y. E., Pillay, V., du Toit, L. C., Modi, G., Naidoo, D., Ndesendo, V. M., and Sibambo, S. R. (2009). Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Int. J. Mol. Sci. 10, 2510-2557.
39. Chuang, S. C., Zhao, W., Bauchwitz, R., Yan, Q., Bianchi, R., and Wong, R. K. (2005). Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J. Neurosci. 25, 8048-8055.
40. Chubykin, A. A., Atasoy, D., Etherton, M. R., Brose, N., Kavalali, E. T., Gibson, J. R., and Sudhof, T. C. (2007). Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919-931.
41. Colonnier, M. (1968). Synaptic patterns on different cell types in the different laminae of the cat visual cortex. An electron microscope study. Brain Res. 9, 268-287.
42. Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., and Greenough, W. T. (1997). Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U.S.A. 94, 5401-5404.
43. Comoletti, D., Flynn, R., Jennings, L. L., Chubykin, A., Matsumura, T., Hasegawa, H., Sudhof, T. C., and Taylor, P. (2003). Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta. J. Biol. Chem. 278, 50497-50505.
44. Cook, E. H. Jr., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., Lincoln, A., Nix, K., Haas, R., Leventhal, B. L., and Courchesne, E. (1998). Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am. J. Hum. Genet. 62, 1077-1083.
45. Cornish, K., Turk, J., and Hagerman, R. (2008). The fragile X continuum: new advances and perspectives. J. Intellect. Disabil. Res. 52, 469-482.
46. Cornish, K. M., Munir, F., and Cross, G. (2001). Differential impact of the FMR-1 full mutation on memory and attention functioning: a neuropsychological perspective. J. Cogn. Neurosci. 13, 144-150.
47. Coury, D. (2010). Medical treatment of autism spectrum disorders. Curr. Opin. Neurol. 23, 131-136.
48. Craig, A. M., Graf, E. R., and Linhoff, M. W. (2006). How to build a central synapse: clues from cell culture. Trends Neurosci. 29, 8-20.
49. Craig, A. M., and Kang, Y. (2007). Neurexin-neuroligin signaling in synapse development. Curr. Opin. Neurobiol. 17, 43-52.
50. Cummings, D. M., Andre, V. M., Uzgil, B. O., Gee, S. M., Fisher, Y. E., Cepeda, C., and Levine, M. S. (2009). Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J. Neurosci. 29, 10371-10386.
51. Curia, G., Papouin, T., Seguela, P., and Avoli, M. (2009). Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb. Cortex 19, 1515-1520.
52. D'Antuono, M., Merlo, D., and Avoli, M. (2003). Involvement of cholinergic and gabaergic systems in the fragile X knockout mice. Neuroscience 119, 9-13.
53. D'Hulst, C., Atack, J. R., and Kooy, R. F. (2009a). The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discov. Today 14, 866-875.
54. D'Hulst, C., Heulens, I., Brouwer, J. R., Willemsen, R., De Geest, N., Reeve, S. P., De Deyn, P. P., Hassan, B. A., and Kooy, R. F. (2009b). Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). Brain Res. 1253, 176-183.
55. D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., and Kooy, R. F. (2006). Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res. 1121, 238-245.
56. D'Hulst, C., and Kooy, R. F. (2007). The GABAA receptor: a novel target for treatment of fragile X? Trends Neurosci. 30, 425-431.
57. D'Hulst, C., and Kooy, R. F. (2009). Fragile X syndrome: from molecular genetics to therapy. J. Med. Genet. 46, 577-584.
58. Dahlhaus, R., and El-Husseini, A. (2009). Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome. Behav. Brain Res. 208, 96-105.
59. Dahlhaus, R., Hines, R. M., Eadie, B. D., Kannangara, T. S., Hines, D. J., Brown, C. E., Christie, B. R., and El-Husseini, A. (2009). Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus. Hippocampus 20, 305-322.
60. Dani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., and Nelson, S. B. (2005). Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U.S.A. 102, 12560-12565.
61. Dani, V. S., and Nelson, S. B. (2009). Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J. Neurosci. 29, 11263-11270.
62. Davis, G. W. (2006). Homeostatic control of neural activity: from phenomenology to molecular design. Annu. Rev. Neurosci. 29, 307-323.
63. Delahanty, R. J., Kang, J. Q., Brune, C. W., Kistner, E. O., Courchesne, E., Cox, N. J., Cook, E. H. Jr., Macdonald, R. L., and Sutcliffe, J. S. (2009). Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol. Psychiatry. doi:10.1038/mp.2009.118. [Epub ahead of print].
64. del Gaudio, D., Fang, P., Scaglia, F., Ward, P. A., Craigen, W.J., Glaze, D. G., Neul, J. L., Patel, A., Lee, J. A., Irons, M., Berry, S. A., Pursley, A. A., Grebe, T. A., Freedenberg, D., Martin, R. A., Hsich, G. E., Khera, J. R., Friedman, N. R., Zoghbi, H. Y., Eng, C. M., Lupski, J. R., Beaudet, A. L., Cheung, S. W., and Roa, B. B. (2006). Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet. Med. 8, 784-792.
65. Desai, N. S., Casimiro, T. M., Gruber, S. M., and Vanderklish, P. W. (2006). Early postnatal plasticity in neocortex of Fmr1 knockout mice. J. Neurophysiol. 96, 1734-1745.
66. de Vrij, F. M., Levenga, J., van der Linde, H. C., Koekkoek, S. K., De Zeeuw, C. I., Nelson, D. L., Oostra, B. A., and Willemsen, R. (2008). Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol. Dis. 31, 127-132.
67. Di Bonaventura, C., Mari, F., Pierallini, A., Mecarelli, O., Randi, F., Manfredi, M., Prencipe, M., and Giallonardo, A. T. (2006). Status epilepticus in a patient with fragile X syndrome: electro-clinical features and peri-ictal neuroimaging. Epileptic Disord. 8, 195-199.
68. Dictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H., and Bassell, G. J. (2008). A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 14, 926-939.
69. Dolen, G., Osterweil, E., Rao, B. S., Smith, G. B., Auerbach, B. D., Chattarji, S., and Bear, M. F. (2007). Correction of Fragile X syndrome in mice. Neuron 56, 955-962.
70. Dubnau, J., Chiang, A. S., Grady, L., Barditch, J., Gossweiler, S., McNeil, J., Smith, P., Buldoc, F., Scott, R., Certa, U., Broger, C., and Tully, T. (2003). The staufen/pumilio pathway is involved in Drosophila long-term memory. Curr. Biol. 13, 286-296.
71. Dudanova, I., Tabuchi, K., Rohlmann, A., Sudhof, T. C., and Missler, M. (2007). Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation. J. Comp. Neurol. 502, 261-274.
72. Dudek, F. E., and Sutula, T. P. (2007). Epileptogenesis in the dentate gyrus: a critical perspective. Prog. Brain Res. 163, 755-773.
73. Dugre-Brisson, S., Elvira, G., Boulay, K., Chatel-Chaix, L., Mouland, A. J., and DesGroseillers, L. (2005). Interaction of Staufen1 with the 5' end of mRNA facilitates translation of these RNAs. Nucleic Acids Res. 33, 4797-4812.
74. Duncan, R. S., Hwang, S. Y., and Koulen, P. (2005). Effects of Vesl/Homer proteins on intracellular signaling. Exp. Biol. Med. 30, 527-535.
75. Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsater, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M. C., de Mas, P., Bieth, E., Roge, B., Heron, D., Burglen, L., Gillberg, C., Leboyer, M., and Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25-27.
76. El Idrissi, A., Ding, X. H., Scalia, J., Trenkner, E., Brown, W. T., and Dobkin, C. (2005). Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci. Lett. 377, 141-146.
77. Essrich, C., Lorez, M., Benson, J. A., Fritschy, J. M., and Luscher, B. (1998). Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat. Neurosci. 1, 563-571.
78. Estes, P. S., O'Shea, M., Clasen, S., and Zarnescu, D. C. (2008). Fragile X protein controls the efficacy of mRNA transport in Drosophila neurons. Mol. Cell. Neurosci. 39, 170-179.
79. Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., and Realmuto, G. R. (2002). Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805-810.
80. Fatemi, S. H., Reutiman, T. J., Folsom, T. D., Rooney, R. J., Patel, D. H., and Thuras, P. D. (2010). mRNA and protein levels for GABA(A)alpha4, alpha5, beta1 and GABA (B)R1 receptors are altered in brains from subjects with autism. J. Autism Dev. Disord. 40, 743-750.
81. Fatemi, S. H., Reutiman, T. J., Folsom, T. D., and Thuras, P. D. (2009). GABA(A) receptor downregulation in brains of subjects with autism. J. Autism Dev. Disord. 39, 223-230.
82. Feng, J., Schroer, R., Yan, J., Song, W., Yang, C., Bockholt, A., Cook, E. H., Jr., Skinner, C., Schwartz, C. E., and Sommer, S. S. (2006). High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci. Lett. 409, 10-13.
83. Flavell, S. W., Cowan, C. W., Kim, T. K., Greer, P. L., Lin, Y., Paradis, S., Griffith, E. C., Hu, L. S., Chen, C., and Greenberg, M. E. (2006). Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008-1012.
84. Fritschy, J. M. (2008). Epilepsy, E/I balance and GABA(A) receptor plasticity. Front. Mol. Neurosci. 1:5. doi:10.3389/neuro.02.005.2008.
85. Fritschy, J. M., Harvey, R. J., and Schwarz, G. (2008). Gephyrin: where do we stand, where do we go? Trends Neurosci. 31, 257-264.
86. Gabel, L. A., Won, S., Kawai, H., McKinney, M., Tartakoff, A. M., and Fallon, J. R. (2004). Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein. J. Neurosci. 24, 10579-10583.
87. Galvez, R., Gopal, A. R., and Greenough, W. T. (2003). Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome. Brain Res. 971, 83-89.
88. Gantois, I., Vandesompele, J., Speleman, F., Reyniers, E., D'Hooge, R., Severijnen, L. A., Willemsen, R., Tassone, F., and Kooy, R. F. (2006). Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol. Dis. 21, 346-357.
89. Garber, K. B., Visootsak, J., and Warren, S. T. (2008). Fragile X syndrome. Eur. J. Hum. Genet. 16, 666-672.
90. Gatto, C. L., and Broadie, K. (2008). Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure. Development 135, 2637-2648.
91. Gatto, C. L., and Broadie, K. (2009a). Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture. Front. Neural Circuits 3:8. doi:10.3389/neuro.04.008.2009.
92. Gatto, C. L., and Broadie, K. (2009b). The fragile X mental retardation protein in circadian rhythmicity and memory consolidation. Mol. Neurobiol. 39, 107-129.
93. Gibson, J. R., Bartley, A. F., Hays, S. A., and Huber, K. M. (2008). Imbalance of neocortical excitation and inhibition and altered up states reflect network hyperexcitability in the mouse model of Fragile X Syndrome. J. Neurophysiol. 100, 2615-2626.
94. Gillespie, D. C., Kim, G., and Kandler, K. (2005). Inhibitory synapses in the developing auditory system are glutamatergic. Nat. Neurosci. 8, 332-338.
95. Glaze, D. G. (2002). Neurophysiology of Rett syndrome. Ment. Retard Dev. Disabil. Res. Rev. 8, 66-71.
96. Glykys, J., and Mody, I. (2006). Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice. J. Neurophysiol. 95, 2796-2807.
97. Goetze, B., Tuebing, F., Xie, Y., Dorostkar, M. M., Thomas, S., Pehl, U., Boehm, S., Macchi, P., and Kiebler, M. A. (2006). The brain-specific double-stranded RNA-binding protein Staufen2 is required for dendritic spine morphogenesis. J. Cell Biol. 172, 221-231.
98. Gossett, L. A., Kelvin, D. J., Sternberg, E. A., and Olson, E. N. (1989). A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9, 5022-5033.
99. Gould, E. L., Loesch, D. Z., Martin, M. J., Hagerman, R. J., Armstrong, S. M., and Huggins, R. M. (2000). Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am. J. Med. Genet. 95, 307-315.
100. Graf, E. R., Zhang, X., Jin, S. X., Linhoff, M. W., and Craig, A. M. (2004). Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119, 1013-1026.
101. Gray, E. G. (1959). Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscope study. J. Anat. 93, 420-433.
102. Greenough, W. T., Klintsova, A. Y., Irwin, S. A., Galvez, R., Bates, K. E., and Weiler, I. J. (2001). Synaptic regulation of protein synthesis and the fragile X protein. Proc. Natl. Acad. Sci. U.S.A. 98, 7101-7106.
103. Gruss, M., and Braun, K. (2001). Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. Neural Plast. 8, 285-298.
104. Gruss, M., and Braun, K. (2004). Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem. Int. 45, 81-88.
105. Gulyas, A. I., Megias, M., Emri, Z., and Freund, T. F. (1999). Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J. Neurosci. 19, 10082-10097.
106. Gutierrez, R. C., Hung, J., Zhang, Y., Kertesz, A. C., Espina, F. J., and Colicos, M. A. (2009). Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3. Neuroscience 162, 208-221.
107. Guy, J., Hendrich, B., Holmes, M., Martin, J. E., and Bird, A. (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322-326.
108. Hagerman, P. J. (2008a). The fragile X prevalence paradox. J. Med. Genet. 45, 498-499.
109. Hagerman, R. (2008b). Commonalities in the neurobiology between autism and fragile X. J. Intellect. Disabil. Res. 52, 817.
110. Hagerman, P. J., and Stafstrom, C. E. (2009). Origins of epilepsy in fragile x syndrome. Epilepsy Curr. 9, 108-112.
111. Hall, S. S., Burns, D. D., Lightbody, A. A., and Reiss, A. L. (2008). Longitudinal changes in intellectual development in children with Fragile X syndrome. J. Abnorm. Child. Psychol. 36, 927-939.
112. Han, K., and Kim, E. (2008). Synaptic adhesion molecules and PSD-95. Prog. Neurobiol. 84, 263-283.
113. Harris, S. W., Hessl, D., Goodlin-Jones, B., Ferranti, J., Bacalman, S., Barbato, I., Tassone, F., Hagerman, P. J., Herman, H., and Hagerman, R. J. (2008). Autism profiles of males with fragile X syndrome. Am. J. Ment. Retard. 113, 427-438.
114. Hatton, D. D., Hooper, S. R., Bailey, D. B., Skinner, M. L., Sullivan, K. M., and Wheeler, A. (2002). Problem behavior in boys with fragile X syndrome. Am. J. Med. Genet. 108, 105-116.
115. Hines, R. M., Wu, L., Hines, D. J., Steenland, H., Mansour, S., Dahlhaus, R., Singaraja, R. R., Cao, X., Sammler, E., Hormuzdi, S. G., Zhuo, M., and El-Husseini, A. (2008). Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression. J. Neurosci. 28, 6055-6067.
116. Hinton, V. J., Brown, W. T., Wisniewski, K., and Rudelli, R. D. (1991). Analysis of neocortex in three males with the fragile X syndrome. Am. J. Med. Genet. 41, 289-294.
117. Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., and Zalutsky, R. (2007). How common are the "common" neurologic disorders? Neurology 68, 326-337.
118. Huber, K. M., Gallagher, S. M., Warren, S. T., and Bear, M. F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U.S.A. 99, 7746-7750.
119. Hung, A. Y., Futai, K., Sala, C., Valtschanoff, J. G., Ryu, J., Woodworth, M. A., Kidd, F. L., Sung, C. C., Miyakawa, T., Bear, M. F., Weinberg, R. J., and Sheng, M. (2008). Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J. Neurosci. 28, 1697-1708.
120. Huppke, P., Kohler, K., Brockmann, K., Stettner, G. M., and Gartner, J. (2007). Treatment of epilepsy in Rett syndrome. Eur. J. Paediatr. Neurol. 11, 10-16.
121. Irwin, S. A., Christmon, C. A., Grossman, A. W., Galvez, R., Kim, S. H., Degrush, B. J., Weiler, I. J., and Greenough, W. T. (2005). Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis. Neurobiol. Learn. Mem. 83, 180-187.
122. Irwin, S. A., Swain, R. A., Christmon, C. A., Chakravarti, A., Weiler, I. J., and Greenough, W. T. (2000). Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol. Learn. Mem. 73, 87-93.
123. Jacob, F. D., Ramaswamy, V., Andersen, J., and Bolduc, F. V. (2009a). Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur. J. Hum. Genet. 17, 1577-1581.
124. Jacob, T. C., Wan, Q., Vithlani, M., Saliba, R. S., Succol, F., Pangalos, M. N., and Moss, S. J. (2009b). GABA(A) receptor membrane trafficking regulates spine maturity. Proc. Natl. Acad. Sci. U.S.A. 106, 12500-12505.
125. Jacobs, M. P., Leblanc, G. G., Brooks-Kayal, A., Jensen, F. E., Lowenstein, D. H., Noebels, J. L., Spencer, D. D., and Swann, J. W. (2009). Curing epilepsy: progress and future directions. Epilepsy Behav. 14, 438-445.
126. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., and Bourgeron, T. (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34, 27-29.
127. Job, C., and Eberwine, J. (2001). Identification of sites for exponential translation in living dendrites. Proc. Natl. Acad. Sci. U.S.A. 98, 13037-13042.
128. Kang, J. Q., and Macdonald, R. L. (2009). Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies. Trends. Mol. Med. 15, 430-438.
129. Kang, Y., Zhang, X., Dobie, F., Wu, H., and Craig, A. M. (2008). Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J. Biol. Chem. 283, 2323-2334.
130. Kato, A., Ozawa, F., Saitoh, Y., Fukazawa, Y., Sugiyama, H., and Inokuchi, K. (1998). Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J. Biol. Chem. 273, 23969-23975.
131. Kau, A. S., Tierney, E., Bukelis, I., Stump, M. H., Kates, W. R., Trescher, W. H., and Kaufmann, W. E. (2004). Social behavior profile in young males with fragile X syndrome: characteristics and specificity. Am. J. Med. Genet. 126A, 9-17.
132. Kehrer, C., Maziashvili, N., Dugladze, T., and Gloveli, T. (2008). Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia. Front. Mol. Neurosci. 1:6. doi:10.3389/neuro.02.006.2008.
133. Keith, D., and El-Husseini, A. (2008). Excitation control: balancing PSD-95 function at the synapse. Front. Mol. Neurosci. 1:4. doi:10.3389/neuro.02.004.2008.
134. Kilman, V., van Rossum, M. C., and Turrigiano, G. G. (2002). Activity deprivation reduces miniature IPSC amplitude by decreasing the number of postsynaptic GABA(A) receptors clustered at neocortical synapses. J. Neurosci. 22, 1328-1337.
135. Kim, E., and Sheng, M. (2004). PDZ domain proteins of synapses. Nat. rev. 5, 771-781.
136. Kim, H. G., Kishikawa, S., Higgins, A. W., Seong, I. S., Donovan, D. J., Shen, Y., Lally, E., Weiss, L. A., Najm, J., Kutsche, K., Descartes, M., Holt, L., Braddock, S., Troxell, R., Kaplan, L., Volkmar, F., Klin, A., Tsatsanis, K., Harris, D. J., Noens, I., Pauls, D. L., Daly, M. J., MacDonald, M. E., Morton, C. C., Quade, B. J., and Gusella, J. F. (2008). Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 82, 199-207.
137. Kim, K. C., and Kim, H. K. (2006). Role of Staufen in dendritic mRNA transport and its modulation. Neurosci. Lett. 397, 48-52.
138. Kim, Y. K., Furic, L., Desgroseillers, L., and Maquat, L. E. (2005). Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. Cell 120, 195-208.
139. Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., O'Donovan, M. C., Erdogan, F., Owen, M. J., Ropers, H. H., and Ullmann, R. (2008). Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 17, 458-465.
140. Kirsch, J., Langosch, D., Prior, P., Littauer, U. Z., Schmitt, B., and Betz, H. (1991). The 93-kDa glycine receptor-associated protein binds to tubulin. J. Biol. Chem. 266, 22242-22245.
141. Kluger, G., Bohm, I., Laub, M. C., and Waldenmaier, C. (1996). Epilepsy and fragile X gene mutations. Pediatr. Neurol. 15, 358-360.
142. Kneussel, M., Brandstatter, J. H., Laube, B., Stahl, S., Muller, U., and Betz, H. (1999). Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. J. Neurosci. 19, 9289-9297.
143. Kullmann, D. M. (2010). Neurological channelopathies. Annu. Rev. Neurosci. 33, [Epub ahead of print]
144. Kumar, R. A., and Christian, S. L. (2009). Genetics of autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 9, 188-197.
145. Kwon, H., Menon, V., Eliez, S., Warsofsky, I. S., White, C. D., Dyer-Friedman, J., Taylor, A. K., Glover, G. H., and Reiss, A. L. (2001). Functional neuroanatomy of visuospatial working memory in fragile X syndrome: relation to behavioral and molecular measures. Am. J. Psychiatry 158, 1040-1051.
146. Laggerbauer, B., Ostareck, D., Keidel, E. M., Ostareck-Lederer, A., and Fischer, U. (2001). Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10, 329-338.
147. Landa, R. J., Holman, K. C., and Garrett-Mayer, E. (2007). Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch. Gen. Psychiatry 64, 853-864.
148. Lanfranchi, S., Cornoldi, C., Drigo, S., and Vianello, R. (2009). Working memory in individuals with Fragile X syndrome. Child Neuropsychol. 15, 105-119.
149. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M. P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., Laudier, B., Chelly, J., Fryns, J. P., Ropers, H. H., Hamel, B. C., Andres, C., Barthelemy, C., Moraine, C., and Briault, S. (2004). X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74, 552-557.
150. Lebeau, G., Maher-Laporte, M., Topolnik, L., Laurent, C. E., Sossin, W., Desgroseillers, L., and Lacaille, J. C. (2008). Staufen1 regulation of protein synthesis-dependent long-term potentiation and synaptic function in hippocampal pyramidal cells. Mol. Cell. Biol. 28, 2896-2907.
151. Levi, S., Logan, S. M., Tovar, K. R., and Craig, A. M. (2004). Gephyrin is critical for glycine receptor clustering but not for the formation of functional GABAergic synapses in hippocampal neurons. J. Neurosci. 24, 207-217.
152. Levinson, J. N., Chery, N., Huang, K., Wong, T. P., Gerrow, K., Kang, R., Prange, O., Wang, Y. T., and El-Husseini, A. (2005). Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity. J. Biol. Chem. 280, 17312-17319.
153. Levinson, J. N., and El-Husseini, A. (2005a). Building excitatory and inhibitory synapses: balancing neuroligin partnerships. Neuron 48, 171-174.
154. Levinson, J. N., and El-Husseini, A. (2005b). New players tip the scales in the balance between excitatory and inhibitory synapses. Mol. Pain 1, 12.
155. Levy, S. E., Mandell, D. S., and Schultz, R. T. (2009). Autism. Lancet 374, 1627-1638.
156. Li, J., Ashley, J., Budnik, V., and Bhat, M. A. (2007). Crucial role of Drosophila neurexin in proper active zone apposition to postsynaptic densities, synaptic growth, and synaptic transmission. Neuron 55, 741-755.
157. Li, J., Pelletier, M. R., Perez Velazquez, J. L., and Carlen, P. L. (2002). Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol. Cell. Neurosci. 19, 138-151.
158. Li, R. W., Yu, W., Christie, S., Miralles, C. P., Bai, J., Loturco, J. J., and De Blas, A. L. (2005). Disruption of postsynaptic GABA receptor clusters leads to decreased GABAergic innervation of pyramidal neurons. J. Neurochem. 95, 756-770.
159. Li, Z., Zhang, Y., Ku, L., Wilkinson, K. D., Warren, S. T., and Feng, Y. (2001). The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29, 2276-2283.
160. Liao, L., Park, S. K., Xu, T., Vanderklish, P., and Yates, J. R. III (2008). Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc. Natl. Acad. Sci. U.S.A. 105, 15281-15286.
161. Lin, Y., Bloodgood, B. L., Hauser, J. L., Lapan, A. D., Koon, A. C., Kim, T. K., Hu, L. S., Malik, A. N., and Greenberg, M. E. (2008). Activity-dependent regulation of inhibitory synapse development by Npas4. Nature 455, 1198-1204.
162. Liu, G. (2004). Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites. Nat. Neurosci. 7, 373-379.
163. Liu, Y., Zhang, L. I., and Tao, H. W. (2007). Heterosynaptic scaling of developing GABAergic synapses: dependence on glutamatergic input and developmental stage. J. Neurosci. 27, 5301-5312.
164. Lohmann, C., and Bonhoeffer, T. (2008). A role for local calcium signaling in rapid synaptic partner selection by dendritic filopodia. Neuron 59, 253-260.
165. Lu, R., Wang, H., Liang, Z., Ku, L., O'Donnell, W, T., Li, W., Warren, S. T., and Feng, Y. (2004). The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc. Natl. Acad. Sci. U.S.A. 101, 15201-15206.
166. Ma, D. Q., Whitehead, P. L., Menold, M. M., Martin, E. R., Ashley-Koch, A. E., Mei, H., Ritchie, M. D., Delong, G. R., Abramson, R. K., Wright, H. H., Cuccaro, M. L., Hussman, J. P., Gilbert, J. R., and Pericak-Vance, M. A. (2005). Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am. J. Hum. Genet. 77, 377-388.
167. Maffei, A., and Fontanini, A. (2009). Network homeostasis: a matter of coordination. Curr. Opin. Neurobiol. 19, 168-173.
168. Mari, F., Azimonti, S., Bertani, I., Bolognese, F., Colombo, E., Caselli, R., Scala, E., Longo, I., Grosso, S., Pescucci, C., Ariani, F., Hayek, G., Balestri, P., Bergo, A., Badaracco, G., Zappella, M., Broccoli, V., Renieri, A., Kilstrup-Nielsen, C., and Landsberger, N. (2005). CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum. Mol. Genet. 14, 1935-1946.
169. Massey, P. V., and Bashir, Z. I. (2007). Long-term depression: multiple forms and implications for brain function. Trends Neurosci. 30, 176-184.
170. Mee, C. J., Pym, E. C., Moffat, K. G., and Baines, R. A. (2004). Regulation of neuronal excitability through pumilio-dependent control of a sodium channel gene. J. Neurosci. 24, 8695-8703.
171. Megias, M., Emri, Z., Freund, T. F., and Gulyas, A. I. (2001). Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102, 527-540.
172. Mencarelli, M. A., Spanhol-Rosseto, A., Artuso, R., Rondinella, D., De Filippis, R., Bahi-Buisson, N., Nectoux, J., Rubinsztajn, R., Bienvenu, T., Moncla, A., Chabrol, B., Villard, L., Krumina, Z., Armstrong, J., Roche, A., Pineda, M., Gak, E., Mari, F., Ariani, F., and Renieri, A. (2010). Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J. Med. Genet. 47, 49-53.
173. Menon, K. P., Andrews, S., Murthy, M., Gavis, E. R., and Zinn, K. (2009). The translational repressors Nanos and Pumilio have divergent effects on presynaptic terminal growth and postsynaptic glutamate receptor subunit composition. J. Neurosci. 29, 5558-5572.
174. Menon, K. P., Sanyal, S., Habara, Y., Sanchez, R., Wharton, R. P., Ramaswami, M., and Zinn, K. (2004a). The translational repressor Pumilio regulates presynaptic morphology and controls postsynaptic accumulation of translation factor eIF-4E. Neuron 44, 663-676.
175. Menon, V., Leroux, J., White, C. D., and Reiss, A. L. (2004b). Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 101, 3615-3620.
176. Mercaldo, V., Descalzi, G., and Zhuo, M. (2009). Fragile X mental retardation protein in learning-related synaptic plasticity. Mol. Cells 28, 501-507.
177. Miano, S., Bruni, O., Elia, M., Scifo, L., Smerieri, A., Trovato, A., Verrillo, E., Terzano, M. G., and Ferri, R. (2008). Sleep phenotypes of intellectual disability: a polysomnographic evaluation in subjects with Down syndrome and Fragile-X syndrome. Clin. Neurophysiol. 119, 1242-1247.
178. Michel, C. I., Kraft, R., and Restifo, L. L. (2004). Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants. J. Neurosci. 24, 5798-5809.
179. Mientjes, E. J., Nieuwenhuizen, I., Kirkpatrick, L., Zu, T., Hoogeveen-Westerveld, M., Severijnen, L., Rife, M., Willemsen, R., Nelson, D. L., and Oostra, B. A. (2006). The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol. Dis. 21, 549-555.
180. Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K., and Sudhof, T. C. (2003). Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423, 939-948.
181. Moessner, R., Marshall, C. R., Sutcliffe, J. S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P., and Scherer, S. W. (2007). Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81, 1289-1297.
182. Monteggia, L. M., and Kavalali, E. T. (2009). Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission. Biol. Psychiatry 65, 204-210.
183. Morales, J., Hiesinger, P. R., Schroeder, A. J., Kume, K., Verstreken, P., Jackson, F. R., Nelson, D. L., and Hassan, B. A. (2002). Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34, 961-972.
184. Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., and Zoghbi, H. Y. (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 26, 319-327.
185. Moser, S. J., Weber, P., and Lutschg, J. (2007). Rett syndrome: clinical and electrophysiologic aspects. Pediatr. Neurol. 36, 95-100.
186. Muddashetty, R. S., Kelic, S., Gross, C., Xu, M., and Bassell, G. J. (2007). Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J. Neurosci. 27, 5338-5348.
187. Mulvihill, B, W. M., Kirby, R. S., Pettygrove, S., Cunniff, C., Meaney, F. J., Miller, L., Robinson, C., Quintana, G., Kaiser, M. Y., Lee, L. C., Landa, R., Newschaffer, C., Constantino, J., Fitzgerald, R., Daniels, J., Giarelli, E., Pinto-Martin, J., Levy, S. E., Charles, J., Nicholas, J., Durkin, M., Rice, C., Baio, J., Braun, K. V., Yeargin-Allsopp, M., Hepburn, M., Garner, N., Mancilla, K. C., Ratchford, A., Castillo, Y., Kolotos, M., Fitzgerald, R., Bell, P., Meade, R., King, L., Arneson, C., Washington, A., Graham, S., Lance, R., Grummon, N., Plummer, L., Jones, L., Wojcik, J., and Doernberg, N. (2009). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill. Summ. 58, 1-20.
188. Munir, F., Cornish, K. M., and Wilding, J. (2000). Nature of the working memory deficit in fragile-X syndrome. Brain Cogn. 44, 387-401.
189. Musumeci, S. A., Hagerman, R. J., Ferri, R., Bosco, P., Dalla Bernardina, B., Tassinari, C. A., De Sarro, G. B., and Elia, M. (1999). Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40, 1092-1099.
190. Nagarajan, R. P., Hogart, A. R., Gwye, Y., Martin, M. R., and LaSalle, J. M. (2006). Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1, e1-e11.
191. Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., and Sheng, M. (1999). Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23, 569-582.
192. Nakayama, K., Kiyosue, K., and Taguchi, T. (2005). Diminished neuronal activity increases neuron-neuron connectivity underlying silent synapse formation and the rapid conversion of silent to functional synapses. J. Neurosci. 25, 4040-4051.
193. Nimchinsky, E. A., Oberlander, A. M., and Svoboda, K. (2001). Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21, 5139-5146.
194. Noh, J., Seal, R. P., Garver, J. A., Edwards, R. H., and Kandler, K. (2010). Glutamate co-release at GABA/glycinergic synapses is crucial for the refinement of an inhibitory map. Nat. Neurosci. 13, 232-238.
195. Nosyreva, E. D., and Huber, K. M. (2006). Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of Fragile X Syndrome. J. Neurophysiol. 95, 3291-3295.
196. O'Donnell, W. T., and Warren, S. T. (2002). A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25, 315-338.
197. O'Hare, A. (2009). Autism spectrum disorder: diagnosis and management. Arch. Dis. Child. 94, 161-168.
198. Okabe, S. (2007). Molecular anatomy of the postsynaptic density. Mol. Cell. Neurosci. 34, 503-518.
199. Pan, L., Zhang, Y. Q., Woodruff, E., and Broadie, K. (2004). The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation. Curr. Biol. 14, 1863-1870.
200. Park, S., Park, J. M., Kim, S., Kim, J. A., Shepherd, J. D., Smith-Hicks, C. L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A. G., Huganir, R. L., Linden, D. J., and Worley, P. F. (2008). Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 70-83.
201. Pathak, H. R., Weissinger, F., Terunuma, M., Carlson, G. C., Hsu, F. C., Moss, S. J., and Coulter, D. A. (2007). Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy. J. Neurosci. 27, 14012-14022.
202. Penagarikano, O., Mulle, J. G., and Warren, S. T. (2007). The pathophysiology of fragile x syndrome. Annu. Rev. Genomics Hum. Genet. 8, 109-129.
203. Percy, A. K., and Lane, J. B. (2005). Rett syndrome: model of neurodevelopmental disorders. J. Child Neurol. 20, 718-721.
204. Peters, A., and Palay, S. L. (1996). The morphology of synapses. J. Neurocytol. 25, 687-700.
205. Pfeiffer, B. E., and Huber, K. M. (2007). Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. J. Neurosci. 27, 3120-3130.
206. Pfeiffer, B. E., and Huber, K. M. (2009). The state of synapses in fragile X syndrome. Neuroscientist 15, 549-567.
207. Porter, B. E., Judkins, A. R., Clancy, R. R., Duhaime, A., Dlugos, D. J., and Golden, J. A. (2003). Dysplasia: a common finding in intractable pediatric temporal lobe epilepsy. Neurology 61, 365-368.
208. Prange, O., Wong, T. P., Gerrow, K., Wang, Y. T., and El-Husseini, A. (2004). A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc. Natl. Acad. Sci. U.S.A. 101, 13915-13920.
209. Qin, M., Kang, J., Burlin, T. V., Jiang, C., and Smith, C. B. (2005). Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. J. Neurosci. 25, 5087-5095.
210. Qiu, L. F., Hao, Y. H., Li, Q. Z., and Xiong, Z. Q. (2008). Fragile X syndrome and epilepsy. Neurosci. Bull. 24, 338-344.
211. Rakhade, S. N., and Jensen, F. E. (2009). Epileptogenesis in the immature brain: emerging mechanisms. Nat. Rev. Neurol. 5, 380-391.
212. Reid, C. A., Berkovic, S. F., and Petrou, S. (2009). Mechanisms of human inherited epilepsies. Prog. Neurobiol. 87, 41-57.
213. Repicky, S. E., and Broadie, K. (2008). Metabotropic glutamate receptor mediated use-dependent down-regulation of synaptic excitability involves the Fragile X mental retardation protein. J. Neurophysiol. 102, 672-687.
214. Rheims, S., Minlebaev, M., Ivanov, A., Represa, A., Khazipov, R., Holmes, G. L., Ben-Ari, Y., and Zilberter, Y. (2008). Excitatory GABA in rodent developing neocortex in vitro. J. Neurophysiol. 100, 609-619.
215. Rippon, G., Brock, J., Brown, C., and Boucher, J. (2007). Disordered connectivity in the autistic brain: challenges for the "new psychophysiology". Int. J. Psychophysiol. 63, 164-172.
216. Rogers, S. J., Wehner, D. E., and Hagerman, R. (2001). The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J. Dev. Behav. Pediatr. 22, 409-417.
217. Roper, S. N. (1998). In utero irradiation of rats as a model of human cerebrocortical dysgenesis: a review. Epilepsy Res. 32, 63-74.
218. Roper, S. N., Eisenschenk, S., and King, M. A. (1999). Reduced density of parvalbumin- and calbindin D28-immunoreactive neurons in experimental cortical dysplasia. Epilepsy Res. 37, 63-71.
219. Roussignol, G., Ango, F., Romorini, S., Tu, J. C., Sala, C., Worley, P. F., Bockaert, J., and Fagni, L. (2005). Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 25, 3560-3570.
220. Rowen, L., Young, J., Birditt, B., Kaur, A., Madan, A., Philipps, D. L., Qin, S., Minx, P., Wilson, R. K., Hood, L., and Graveley, B. R. (2002). Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 79, 587-597.
221. Rubenstein, J. L., and Merzenich, M. M. (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255-267.
222. Rudelli, R. D., Brown, W. T., Wisniewski, K., Jenkins, E. C., Laure-Kamionowska, M., Connell, F., and Wisniewski, H. M. (1985). Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol. 67, 289-295.
223. Rujescu, D., Ingason, A., Cichon, S., Pietilainen, O. P., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., Murray, R., Ruggeri, M., Tosato, S., Bonetto, C., Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson, H., Gylfason, A., Olason, P. I., Hardarsson, G., Jonsdottir, G. A., Gustafsson, O., Fossdal, R., Giegling, I., Moller, H. J., Hartmann, A. M., Hoffmann, P., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Melle, I., Andreassen, O. A., Hansen, T., Werge, T., Kiemeney, L. A., Franke, B., Veltman, J., Buizer-Voskamp, J. E., Sabatti, C., Ophoff, R. A., Rietschel, M., Nothen, M. M., Stefansson, K., Peltonen, L., St Clair, D., Stefansson, H., and Collier, D. A. (2009). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 18, 988-996.
224. Sabaratnam, M., Vroegop, P. G., and Gangadharan, S. K. (2001). Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure 10, 60-63.
225. Sala, C., Futai, K., Yamamoto, K., Worley, P. F., Hayashi, Y., and Sheng, M. (2003). Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a. J. Neurosci. 23, 6327-6337.
226. Sala, C., Piech, V., Wilson, N. R., Passafaro, M., Liu, G., and Sheng, M. (2001). Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31, 115-130.
227. Scharfman, H. E. (2007). The neurobiology of epilepsy. Curr. Neurol. Neurosci. Rep. 7, 348-354.
228. Schrader, N., Kim, E. Y., Winking, J., Paulukat, J., Schindelin, H., and Schwarz, G. (2004). Biochemical characterization of the high affinity binding between the glycine receptor and gephyrin. J. Biol. Chem. 279, 18733-18741.
229. Schutt, J., Falley, K., Richter, D., Kreienkamp, H. J., and Kindler, S. (2009). Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J. Biol. Chem. 284, 25479-25487.
230. Schweizer, C., Balsiger, S., Bluethmann, H., Mansuy, I. M., Fritschy, J. M., Mohler, H., and Luscher, B. (2003). The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol. Cell. Neurosci. 24, 442-450.
231. Segawa, M., and Nomura, Y. (2005). Rett syndrome. Curr. Opin. Neurol. 18, 97-104.
232. Selby, L., Zhang, C., and Sun, Q. Q. (2007). Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci. Lett. 412, 227-232.
233. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R., and Zoghbi, H. (2002). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243-254.
234. Shao, Y., Cuccaro, M. L., Hauser, E. R., Raiford, K. L., Menold, M. M., Wolpert, C. M., Ravan, S. A., Elston, L., Decena, K., Donnelly, S. L., Abramson, R. K., Wright, H. H., DeLong, G. R., Gilbert, J. R., and Pericak-Vance, M. A. (2003). Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am. J. Hum. Genet. 72, 539-548.
235. Sheng, M., and Kim, E. (2000). The Shank family of scaffold proteins. J. Cell. Sci. 113(Pt 11), 1851-1856.
236. Shi, J., Shibayama, A., Liu, Q., Nguyen, V. Q., Feng, J., Santos, M., Temudo, T., Maciel, P., and Sommer, S. S. (2005). Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by Robust Dosage PCR (RD-PCR). Hum. Mutat. 25, 505.
237. Singh, K., Gaur, P., and Prasad, S. (2007). Fragile x mental retardation (Fmr-1) gene expression is down regulated in brain of mice during aging. Mol. Biol. Rep. 34, 173-181.
238. Singh, R., Sutherland, G. R., and Manson, J. (1999). Partial seizures with focal epileptogenic electroencephalographic patterns in three related female patients with fragile-X syndrome. J. Child Neurol. 14, 108-112.
239. Smyk, M., Obersztyn, E., Nowakowska, B., Nawara, M., Cheung, S. W., Mazurczak, T., Stankiewicz, P., and Bocian, E. (2008). Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 799-806.
240. Sola, M., Bavro, V. N., Timmins, J., Franz, T., Ricard-Blum, S., Schoehn, G., Ruigrok, R. W., Paarmann, I., Saiyed, T., O'Sullivan, G. A., Schmitt, B., Betz, H., and Weissenhorn, W. (2004). Structural basis of dynamic glycine receptor clustering by gephyrin. EMBO J. 23, 2510-2519.
241. Song, J. Y., Ichtchenko, K., Sudhof, T. C., and Brose, N. (1999). Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl. Acad. Sci. U.S.A. 96, 1100-1105.
242. Spigelman, I., Li, Z., Banerjee, P. K., Mihalek, R. M., Homanics, G. E., and Olsen, R. W. (2002). Behavior and physiology of mice lacking the GABAA-receptor delta subunit. Epilepsia 43(Suppl. 5), 3-8.
243. Sprovieri, T., Conforti, F. L., Fiumara, A., Mazzei, R., Ungaro, C., Citrigno, L., Muglia, M., Arena, A., and Quattrone, A. (2009). A novel mutation in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene associated with a severe Rett phenotype. Am. J. Med. Genet. 149A, 722-725.
244. Steward, O., and Schuman, E. M. (2001). Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24, 299-325.
245. Sullivan, K., Hatton, D., Hammer, J., Sideris, J., Hooper, S., Ornstein, P., and Bailey, D. Jr. (2006). ADHD symptoms in children with FXS. Am. J. Med. Genet. 140, 2275-2288.
246. Sun, M., Liu, L., Zeng, X., Xu, M., Liu, L., Fang, M., and Xie, W. (2009). Genetic interaction between Neurexin and CAKI/CMG is important for synaptic function in Drosophila neuromuscular junction. Neurosci. Res. 64, 362-371.
247. Sung, Y. J., Dolzhanskaya, N., Nolin, S. L., Brown, T., Currie, J. R., and Denman, R. B. (2003). The fragile X mental retardation protein FMRP binds elongation factor 1A mRNA and negatively regulates its translation in vivo. J. Biol. Chem. 278, 15669-15678.
248. Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., and Warren, S. T. (1992). DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1, 397-400.
249. Sutton, M. A., and Schuman, E. M. (2006). Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127, 49-58.
250. Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., and Sudhof, T. C. (2007). A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-76.
251. Tabuchi, K., and Sudhof, T. C. (2002). Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 79, 849-859.
252. Tang, S. J., Meulemans, D., Vazquez, L., Colaco, N., and Schuman, E. (2001). A role for a rat homolog of staufen in the transport of RNA to neuronal dendrites. Neuron 32, 463-475.
253. Tervonen, T. A., Louhivuori, V., Sun, X., Hokkanen, M. E., Kratochwil, C. F., Zebryk, P., Castren, E., and Castren, M. L. (2009). Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol. Dis. 33, 250-259.
254. Tessier, C. R., and Broadie, K. (2008). Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning. Development 135, 1547-1557.
255. Tessier, C. R., and Broadie, K. (2009). Activity-dependent modulation of neural circuit synaptic connectivity. Front. Mol. Neurosci. 2:8. doi:10.3389/neuro.02.008.2009.
256. Thind, K. K., Yamawaki, R., Phanwar, I., Zhang, G., Wen, X., and Buckmaster, P. S. (2010). Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J. Comp. Neurol. 518, 647-667.
257. Todd, P. K., and Mack, K. J. (2000). Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. Brain Res. 80, 17-25.
258. Todd, P. K., Mack, K. J., and Malter, J. S. (2003). The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc. Natl. Acad. Sci. U.S.A. 100, 14374-14378.
259. Tretter, V., Jacob, T. C., Mukherjee, J., Fritschy, J. M., Pangalos, M. N., and Moss, S. J. (2008). The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin. J. Neurosci. 28, 1356-1365.
260. Tretter, V., and Moss, S. J. (2008). GABA(A) receptor dynamics and constructing GABAergic synapses. Front. Mol. Neurosci. 1:7. doi:10.3389/neuro.02.007.2008.
261. Tsiouris, J. A., and Brown, W. T. (2004). Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy. CNS Drugs 18, 687-703.
262. Tu, J. C., Xiao, B., Naisbitt, S., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., and Worley, P. F. (1999). Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23, 583-592.
263. Tuchman, R., Moshe, S. L., and Rapin, I. (2009). Convulsing toward the pathophysiology of autism. Brain Dev. 31, 95-103.
264. Tuchman, R., and Rapin, I. (2002). Epilepsy in autism. Lancet Neurol. 1, 352-358.
265. Turrigiano, G. G., Leslie, K. R., Desai, N. S., Rutherford, L. C., and Nelson, S. B. (1998). Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892-896.
266. Turrigiano, G. G., and Nelson, S. B. (2004). Homeostatic plasticity in the developing nervous system. Nat. rev. 5, 97-107.
267. Tyagarajan, S. K., and Fritschy, J. M. (2010). GABA(A) receptors, gephyrin and homeostatic synaptic plasticity. J. Physiol. (Lond.) 588, 101-106.
268. Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., Lugtenberg, D., Bienvenu, T., Jensen, L. R., Gecz, J., Moraine, C., Marynen, P., Fryns, J. P., and Froyen, G. (2005). Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442-453.
269. Varoqueaux, F., Aramuni, G., Rawson, R. L., Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, T. C., and Brose, N. (2006). Neuroligins determine synapse maturation and function. Neuron 51, 741-754.
270. Varoqueaux, F., Jamain, S., and Brose, N. (2004). Neuroligin 2 is exclusively localized to inhibitory synapses. Eur. J. Cell Biol. 83, 449-456.
271. Ventura, R., Pascucci, T., Catania, M. V., Musumeci, S. A., and Puglisi-Allegra, S. (2004). Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav. Pharmacol. 15, 433-442.
272. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F. P., Eussen, B. E., van Ommen, G-J.B., Blonden, L. A. J., Riggins, G. J., Chastain, J. L., Kunst, C. B., Galjaard, H., Caskey, C. T., Nelson, D. L., Oostra, B. A., and Warren, S. T. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
273. Vessey, J. P., Schoderboeck, L., Gingl, E., Luzi, E., Riefler, J., Di Leva, F., Karra, D., Thomas, S., Kiebler, M. A., and Macchi, P. (2010). Mammalian Pumilio 2 regulates dendrite morphogenesis and synaptic function. Proc. Natl. Acad. Sci. U.S.A. 107, 3222-3227.
274. Villace, P., Marion, R. M., and Ortin, J. (2004). The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 32, 2411-2420.
275. Volk, L. J., Pfeiffer, B. E., Gibson, J. R., and Huber, K. M. (2007). Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. J. Neurosci. 27, 11624-11634.
276. Vrijenhoek, T., Buizer-Voskamp, J. E., van der Stelt, I., Strengman, E., Sabatti, C., Geurts van Kessel, A., Brunner, H. G., Ophoff, R. A., and Veltman, J. A. (2008). Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am. J. Hum. Genet. 83, 504-510.
277. Wang, H., Wu, L. J., Kim, S. S., Lee, F. J., Gong, B., Toyoda, H., Ren, M., Shang, Y. Z., Xu, H., Liu, F., Zhao, M. G., and Zhuo, M. (2008). FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59, 634-647.
278. Wassef, A., Baker, J., and Kochan, L. D. (2003). GABA and schizophrenia: a review of basic science and clinical studies. J. Clin. Psychopharmacol. 23, 601-640.
279. Waung, M. W., and Huber, K. M. (2009). Protein translation in synaptic plasticity: mGluR-LTD, Fragile X. Curr. Opin. Neurobiol. 19, 319-326.
280. Weaving, L. S., Christodoulou, J., Williamson, S. L., Friend, K. L., McKenzie, O. L., Archer, H., Evans, J., Clarke, A., Pelka, G. J., Tam, P. P., Watson, C., Lahooti, H., Ellaway, C. J., Bennetts, B., Leonard, H., and Gecz, J. (2004). Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75, 1079-1093.
281. Weiler, I. J., and Greenough, W. T. (1993). Metabotropic glutamate receptors trigger postsynaptic protein synthe sis. Proc. Natl. Acad. Sci. U.S.A. 90, 7168-7171.
282. Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., and Greenough, W. T. (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U.S.A. 94, 5395-5400.
283. Weiler, I. J., Spangler, C. C., Klintsova, A. Y., Grossman, A.W., Kim, S. H., Bertaina-Anglade, V., Khaliq, H., de Vries, F. E., Lambers, F. A., Hatia, F., Base, C. K., and Greenough, W. T. (2004). Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc. Natl. Acad. Sci. U.S.A. 101, 17504-17509.
284. Westmark, C. J., and Malter, J. S. (2007). FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 5, e52. doi:10.1371/journal.pbio.0050052.
285. Wierenga, C. J., Becker, N., and Bonhoeffer, T. (2008). GABAergic synapses are formed without the involvement of dendritic protrusions. Nat. Neurosci. 11, 1044-1052.
286. Wilson, B. M., and Cox, C. L. (2007). Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc. Natl. Acad. Sci. U.S.A. 104, 2454-2459.
287. Wood, L., Gray, N. W., Zhou, Z., Greenberg, M. E., and Shepherd, G. M. (2009). Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J. Neurosci. 29, 12440-12448.
288. Wulffaert, J., Van Berckelaer-Onnes, I. A., and Scholte, E. M. (2009). Autistic disorder symptoms in Rett syndrome. Autism 13, 567-581.
289. Xiang, H., Chen, H. X., Yu, X. X., King, M. A., and Roper, S. N. (2006). Reduced sis excitatory drive in interneurons in an animal model of cortical dysplasia. J. Neurophysiol. 96, 569-578.
290. Xiao, B., Tu, J. C., and Worley, P. F. (2000). Homer: a link between neural activity and glutamate receptor function. Curr. Opin. Neurobiol. 10, 370-374.
291. Yan, J., Noltner, K., Feng, J., Li, W., Schroer, R., Skinner, C., Zeng, W., Schwartz, C. E., and Sommer, S. S. (2008). Neurexin 1alpha structural variants associated with autism. Neurosci. Lett. 438, 368-370.
292. Yan, Q. J., Rammal, M., Tranfaglia, M., and Bauchwitz, R. P. (2005). Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053-1066.
293. Yu, W., and De Blas, A. L. (2008). Gephyrin expression and clustering affects the size of glutamatergic synaptic contacts. J. Neurochem. 104, 830-845.
294. Yu, W., Jiang, M., Miralles, C. P., Li, R. W., Chen, G., and de Blas, A. L. (2007). Gephyrin clustering is required for the stability of GABAergic synapses. Mol. Cell. Neurosci. 36, 484-500.
295. Zalfa, F., Adinolfi, S., Napoli, I., Kuhn-Holsken, E., Urlaub, H., Achsel, T., Pastore, A., and Bagni, C. (2005). Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J. Biol. Chem. 280, 33403-33410.
296. Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., De Rubeis, S., di Penta, A., Tabolacci, E., Chiurazzi, P., Neri, G., Grant, S. G., and Bagni, C. (2007). A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat. Neurosci. 10, 578-587.
297. Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., and Bagni, C. (2003). The fragile X syn drome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112, 317-327.
298. Zeng, X., Sun, M., Liu, L., Chen, F., Wei, L., and Xie, W. (2007). Neurexin-1 is required for synapse formation and larvae associative learning in Drosophila. FEBS Lett. 581, 2509-2516.
299. Zhang, A., Shen, C. H., Ma, S. Y., Ke, Y., and El Idrissi, A. (2009). Altered expression of Autism-associated genes in the brain of Fragile X mouse model. Biochem. Biophys. Res. Commun. 379, 920-923.
300. Zhang, L., He, J., Jugloff, D. G., and Eubanks, J. H. (2008). The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18, 294-309.
301. Zhang, M., Wang, Q., and Huang, Y. (2007). Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells. Proc. Natl. Acad. Sci. U.S.A. 104, 10057-10062.
302. Zhang, Y. Q., Bailey, A. M., Matthies, H. J., Renden, R. B., Smith, M. A., Speese, S. D., Rubin, G. M., and Broadie, K. (2001). Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107, 591-603.
303. Zhang, Y. Q., Friedman, D. B., Wang, Z., Woodruff, E., 3rd, Pan, L., O'Donnell, J., and Broadie, K. (2005). Protein expression profiling of the Drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mol. Cell Proteomics 4, 278-290.
304. Zhao, M. G., Toyoda, H., Ko, S. W., Ding, H. K., Wu, L. J., and Zhuo, M. (2005). Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J. Neurosci. 25, 7385-7392.
305. Zhou, F. W., Chen, H. X., and Roper, S. N. (2009). Balance of inhibitory and excitatory synaptic activity is altered in fast-spiking interneurons in experimental cortical dysplasia. J. Neurophysiol. 102, 2514-2525.
306. Zhu, W. J., and Roper, S. N. (2000). Reduced inhibition in an animal model of cortical dysplasia. J. Neurosci. 20, 8925-8931.
307. Zwaigenbaum, L. (2010). Advances in the early detection of autism. Curr. Opin. Neurol. 23, 97-102.
308. Zweier, C., de Jong, E. K., Zweier, M., Orrico, A., Ousager, L. B., Collins, A.L., Bijlsma, E. K., Oortveld, M. A., Ekici, A. B., Reis, A., Schenck, A., and Rauch, A. (2009). CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am. J. Hum. Genet. 85, 655-666.